Download Free Sample Report

This report contains market size and forecasts of Drugs for Short Bowel Syndrome in Global, including the following market information:

• Global Drugs for Short Bowel Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Drugs for Short Bowel Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GLP-2 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Short Bowel Syndrome include Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company and Takeda and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Short Bowel Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Short Bowel Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Type, 2021 (%)

• GLP-2
• Growth Hormone
• Glutamine
• Other

Global Drugs for Short Bowel Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Drugs for Short Bowel Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Drugs for Short Bowel Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Drugs for Short Bowel Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ardelyx
• Emmaus Life Sciences
• GLyPharma Therapeutic
• Merck
• Naia Pharmaceuticals
• Nutrinia
• OxThera
• Sancilio & Company
• Takeda
• Zealand Pharma